Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy + Stereotactic Radiotherapy vs Stereotactic Radiotherapy Alone in HNSCC Oligometastases
NCT03070366Phase 2Active, not recruiting
- Sponsor
- GORTEC
- Start
- Sep 2015
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), fluorouracil, carboplatin, KL-140 in head and neck squamous cell carcinoma (HNSCC), sponsored by GORTEC. Started Sep 2015; status: active, not recruiting.
02
Drugs
Cisplatin micelle injection (HA132)fluorouracilcarboplatinKL-140
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03070366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070366.